Education and Experience

• AB Harvard
• PhD Princeton
• President, PMC Group International
• Launched PMC’s pharmaceutical manufacturing & CRO division
• Founder, Chakrabarti Advanced Technology
• Formerly Prof. of Chemical Engineering and Faculty, Program in Computational Science and Engineering, Purdue University (top 10 global engineering university)
• Prof. of Chemical Engineering and Faculty, Center for Advanced Process Decision Making, Carnegie Mellon University (top 6 global engineering university)

Awards and Honors

• Winner, Intel International Science and Engineering Competition (one of two in the world)
• USA Today All-Academic First Team (one of 20 in the nation)
• American Academy of Achievement Golden Eagle Award for the Nation’s Most Promising Exemplars of Achievement (one of 6 in the nation)
• Invited speaker at Harvard, MIT, Princeton, Yale, University of Pennsylvania, Cornell Departments of Chemistry, Chemical Engineering and Biophysics
• Lead inventor of biotechnology patents commercialized by/with industry leaders Celera Genomics, New England Biolabs, Abbott, Quest Diagnostics, which generate $40M annual revenue (top 0.1% of revenue generating patents at Princeton University).

Expertise

• Process Systems Engineering: Performance optimization of chemical processes and operations
• Pharmaceuticals and Biotechnology

Education and Experience

• PhD Organic Chemistry, Paris University - Chemical Engineer, ESCOM
• Former Head of R&D Process Development - Minakem
• R&D Senior Manager - PMC Isochem

Expertise

• Over 20 years of experience in pharmaceutical chemistry and R&D

Education and Experience

• PhD, Paris Descartes University, France. ESPCI Paris - PSL Alumni
• Formerly Head of MedChem Laboratory at Roowin (French CRO)
• Formerly Head of Process development - R&D Department at PMC Isochem

Expertise

• Over 10 years in Pharma R&D (Medicinal Chemistry, Process development, Biotechnologies, high throughput drug discovery technologies)

Education and Experience

• Ph.D. of Cell and Molecular Biology. Art and Science School, University of Pennsylvania
• Post Doctoral Fellow. University of Pennsylvania
• Scientific Fellow. Food and Drug Administration, Silver Spring Campus, Maryland
• Scientific Fellow. Medical School of University of Pennsylvania
• Head Scientist. Biologen Biotech LTD.
• Principal Scientist. Wuxi Biologics

Expertise

• Molecular Biology
• Cell Biology
• Biochemistry
• Immunology

Education and Experience

• Prof. of Cancer Biology, Ohio State Cancer Center

Expertise

• Over 30 years of experience in preclinical cancer therapeutic development

Background and Expertise

• Partner, CCD Partners
• CBO, Exvastat
• Formerly CEO of Avantium Pharmaceuticals and Crystallics
• Over 20 years of extensive commercial leadership experience in the Life Science sector

Education and Background

• Professor of Pharmaceutics and Pharmacology, Ohio State University
• >20 years of experience in preclinical therapeutic development
• Prior Director of Preclinical Development for the RNAi therapeutics company, Microlin

Expertise

• Targeted drug delivery systems based on nanoparticles, including miR-targeting lipid nanoparticles and targeted chemotherapeutic drug formulations and bioconjugates for therapy of solid tumors, leukemias, diabetic wounds, and other diseases.

Education and Background

• PhD, London School of Economics
• Professor of Finance, McGill University (On Leave)
• Formerly Professor of Finance, Carnegie Mellon university
• Research cited in the 2014 Nobel prize lecture in economics
• Academic Director, Honors in Investment Management Program, McGill University, which manages Desautels Capital Management

Education and Experience

• PhD Jawaharlal Nehru Technological University, India
• Experienced operational and leadership in the API industry who has successfully built high-performing teams and delivered a couple of Active Pharmaceutical Ingredient (API) Projects

Expertise

• Technical development of APIs
• Synthetic Organic Chemistry
• Externalization
• Technical transfer
• CMC regulatory submission
• CMC project planning
• Risk identification and mitigation